20/20 GeneSystems
Early Stage
Artificial intelligence-powered diagnostics for cancer & COVID-19
Overview
Raised: $3,792,229
Total Commitments ($USD)
Platform
SeedInvest
Start Date
08/17/2018
Close Date
11/01/2020
Min. Goal
$10
Max. Goal
$14,700,000
Min. Investment
$502
Security Type
Equity - Preferred
SEC Filing Type
RegA+
Price Per Share
$3.53
Pre-Money Valuation
$38,500,000
Rolling Commitments ($USD)
Status
Funded
Reporting Date
11/01/2020
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$4,699
# of Investors
1,710
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2000
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Location
Rockville, Maryland
20/20 GeneSystems, with a pre-money valuation of $38.5 million, is raising funds on SeedInvest through Reg A+ crowdfunding. It is a diagnostics company with a successful track record in cancer detection with its AI-powered multi-cancer blood test, OneTest. The company has recently launched CoronaCheck; its FDA authorized antibody lab test for COVID-19 antibodies. 20/20 GeneSystems was founded by Jonathan Cohen and has raised over $10 million in previous rounds of financing. The current round of funding has round size of $14,700,000, and the proceeds will be used for sales and marketing, research and development, intellectual property development and protection, and cybersecurity and patient privacy protections. 20/20 GeneSystems has already sold over 70,000 COVID-19 antibody tests since its launch in March 2020 and generated over $1.2 million in revenue.
Create a free account today to gain access to KingsCrowd analytics.
Raise History
| Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| 20/20 GeneSystems | 12/21/2022 | StartEngine | $58,400,000 | $232,704 | Convertible Note | Funded | RegCF |
| 20/20 GeneSystems | 06/27/2021 | StartEngine | $38,500,000 | $2,903,017 | Equity - Preferred | Funded | RegA+ |
| 20/20 GeneSystems | 11/01/2020 | SeedInvest | $38,500,000 | $3,792,229 | Equity - Preferred | Funded | RegA+ |
| 20/20 GeneSystems | 12/14/2017 | Microventures | $23,000,000 | $1,064,807 | Equity - Preferred | Funded | RegCF |
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.